Audited Results of Epigral Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	2,527.18	2,550.13	1,929.19	2,188.40	1,550.94
Manufacturing Expenses	156.40	130.08	105.75	122.89	41.13
Personnel Expenses	129.66	114.48	89.65	86.60	76.79
Selling Expenses	0	0	0	0	17.02
Administrative Expenses	177.34	185.55	137.39	122.37	105.18
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	1,960.11	1,839.41	1,447.98	1,499.40	1,041.45
Operating Profit	567.07	710.72	481.21	689	509.49
Other Recurring Income	14.98	15.21	6.51	7.98	4.11
Adjusted PBDIT	582.05	725.93	487.72	696.98	513.60
Financial Expenses	71.96	53.27	73.49	65.50	44.27
Depreciation	168.29	132.56	123.56	108.95	85.91
Other Write offs	0	0	0	0	0
Adjusted PBT	341.80	540.10	290.67	522.53	383.42
Tax Charges	8.79	183.40	94.88	169.17	130.64
Adjusted PAT	333.01	356.70	195.79	353.36	252.79
Non Recurring Items	0.03	-0.42	-0.48	0.23	-0.03
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	333.01	356.70	195.79	353.36	252.79
Equity Dividend	15.10	31.56	10.39	10.39	0
Preference Dividend	0	0	0	0	0
Retained Earnings	2,101.88	1,783.94	1,459.22	1,274.30	931.10

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article